MedTrace Logo

Far Infrared Radiation Treatment of Dementia and Other Mental Illness

NCT00574054 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2009-08-17

No results posted yet for this study

Summary

This trial is a preliminary study to determine the use of far infrared radiation for the treatment of dementia and other mental sickness.

Conditions

Interventions

RADIATION

Far Infrared

Far infrared radiation (5 μm to 20 μm wavelength) for 30 to 40 minutes per treatment session.

Sponsors & Collaborators

  • GAAD Medical Research Institute Inc.

    lead OTHER

Principal Investigators

  • Kwasi Donyina, Ph.D. · GAAD Medical Research Institute Inc.

  • Ken Nedd, M.D. · GAAD Medical Research Institute Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-01-31
Completion
2009-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00574054 on ClinicalTrials.gov